Established in 1967, GC Biopharma is a top ranked pharmaceutical company in South Korea, and an experienced world-leading exporter in 64 countries. With over 55 years of manufacturing experience in biopharma, GC Biopharma is dedicated to manufacturing Drug Products (DP) for vaccines (Sterile vials and PFS) and non-vaccine Fill Finish and Packaging.
Our mission is to exceed customer expectation, to provide one-stop solution service, and to become an accessible & credible partner. GC Biopharma provides the contract manufacturing (CMO) Drug Products service with 100% certified cold chain logistic system. We have three state-of-the-art fill-finish facilities located in South Korea. One of the plant is the largest vaccine manufacturing base in South Korea with WHO PQ approval.
How to contact us :
Location: Yongin-si, Gyeonggi-do, Republic of Korea
Email: joohyun.jo@gccorp.com
Tel: +82 43 906 1940
Company Details
- Founded
- -
- Address
- Yongin-Si, Kr
- Phone
- +82-31-260-9300
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- globalgreencross.com
- Keywords
- Fill-Finish and Packaging and Vaccine, Plasma Derivatives, Recombinant products, Chemicals, OTC.
- HQ
- Yongin-si
Gc Biopharma Cdmo Questions
Gc Biopharma Cdmo's helpline number is +82-31-260-9300
Gc Biopharma Cdmo's website is globalgreencross.com
Gc Biopharma Cdmo's LinkedIn profile is https://kr.linkedin.com/company/gc-pharma-cmo
Gc Biopharma Cdmo's industry is
Pharmaceutical Manufacturing
Gc Biopharma Cdmo's top competitors are
Lamed Venom,
Gc Biopharma Usa, Inc.,
Lukas Biomedical Inc.,
Daewoong Pharmaceutical,
Sk Bioscience,
Gc Cell,
Samsung Biologics,
Hanmi Pharm. Bioplant Cdmo,
Lotte Biologics,
Gc Biopharma (Gc녹십자).
Gc Biopharma Cdmo's categories are Pharmaceutical Manufacturing
Gc Biopharma Cdmo's founding year is 1967
